Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Enovis (ENOV) Research & Development (2021 - 2026)

Enovis has reported Research & Development over the past 7 years, most recently at $31.4 million for Q4 2025.

  • Quarterly Research & Development rose 30.95% to $31.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $120.3 million through Dec 2025, up 31.8% year-over-year, with the annual reading at $120.3 million for FY2025, 31.8% up from the prior year.
  • Research & Development was $31.4 million for Q4 2025 at Enovis, up from $29.7 million in the prior quarter.
  • Over five years, Research & Development peaked at $31.4 million in Q4 2025 and troughed at $11.0 million in Q3 2021.
  • The 5-year median for Research & Development is $18.9 million (2023), against an average of $20.3 million.
  • Year-over-year, Research & Development dropped 3.34% in 2022 and then soared 45.13% in 2025.
  • A 5-year view of Research & Development shows it stood at $15.2 million in 2021, then decreased by 3.34% to $14.7 million in 2022, then grew by 24.41% to $18.3 million in 2023, then skyrocketed by 30.74% to $24.0 million in 2024, then surged by 30.95% to $31.4 million in 2025.
  • Per Business Quant, the three most recent readings for ENOV's Research & Development are $31.4 million (Q4 2025), $29.7 million (Q4 2025), and $30.7 million (Q3 2025).